Rate of neutropenic sepsis in relapsed NSCLC patients receiving docetaxel chemotherapy

被引：0
|
作者：
Gyi, M. M. [1 ]
Gulliford, T. J. [1 ]
Muthuramalingam, S. R. [1 ]
机构：
[1] Portsmouth Oncol Ctr, Oncol, Portsmouth, Hants, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
88
引用
收藏
页码：S41 / S42
页数：2
相关论文
共 50 条
  • [31] PHASE II STUDY ON BIWEEKLY DOCETAXEL AS SECOND-LINE CHEMOTHERAPY FOR NSCLC PATIENTS
    De Petris, Luigi
    Migliorino, Maria Rita
    Ceribelli, Anna
    Martelli, Olga
    Mancuso, Andrea
    di Salvia, Roberto
    Di Molfetta, Michele
    Cipri, Antonio
    Ariganello, Ottaviano
    Diana, Francesco
    De Marinis, Filippo
    ANNALS OF ONCOLOGY, 2004, 15 : 31 - 32
  • [32] Impact of a specialized "Neutropenic" diet on the incidence of foodborne disease, infections, and survival in neutropenic patients receiving anti-cancer chemotherapy
    Vehreschild, J. J.
    Vehreschild, M. J. G. T.
    Wisplinghoff, H.
    Freund, M.
    Faetkenheuer, G.
    Seifert, H.
    Franke, B.
    Mueller, F.
    Heimann, S.
    Engert, A.
    Hallek, M.
    Cornely, A.
    ONKOLOGIE, 2013, 36 : 108 - 108
  • [33] Neutropenic sepsis: a potentially life-threatening complication of chemotherapy
    Ford, Amy
    Marshall, Ernie
    CLINICAL MEDICINE, 2014, 14 (05) : 538 - 542
  • [34] Serum potassium, calcium and magnesium in patients receiving ESHAP chemotherapy for relapsed lymphomas
    Zekri, J.
    Cheah, N. L. C.
    Evans, L.
    Hancock, B.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (04): : 301 - 306
  • [35] Association of Sarcopenia with Survival in Advanced NSCLC Patients Receiving Concurrent Immunotherapy and Chemotherapy
    Bolte, F. J.
    McTavish, S.
    Wakefield, N.
    Shantzer, L.
    Hubbard, C.
    Krishnaraj, A.
    Novicoff, W.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S353 - S353
  • [36] What Factors Determine Treatment Satisfaction in Patients with Advanced NSCLC Receiving Chemotherapy?
    Visser, Sabine
    De Mol, Mark
    Van Walree, Nico
    Van Toor, Jermo
    Den Oudsten, Brenda
    Stricker, Bruno
    Aerts, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S673 - S674
  • [37] Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy
    Bolte, Fabian J. J.
    McTavish, Sloane
    Wakefield, Nathan
    Shantzer, Lindsey
    Hubbard, Caroline
    Krishnaraj, Arun
    Novicoff, Wendy
    Gentzler, Ryan D. D.
    Hall, Richard D. D.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Audit of 1 year survival for patients receiving chemotherapy for NSCLC - all comers
    Allison, J. L. E.
    Lord, H.
    LUNG CANCER, 2016, 91 : S29 - S29
  • [39] Satisfaction with Therapy and the Relation with Quality of Life in Patients with Advanced NSCLC Receiving Chemotherapy
    Visser, Sabine
    De Mol, Mark
    Cheung, C.
    Van Walree, Nico
    Van Toor, Jermo
    Den Oudsten, B. L.
    Stricker, Bruno
    Aerts, Joachim G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S317 - S317
  • [40] REDUCTION IN MORTALITY FROM GRAM-NEGATIVE SEPSIS IN NEUTROPENIC PATIENTS RECEIVING TRIMETHOPRIM SULFAMETHOXAZOLE THERAPY
    RIBEN, PD
    LOUIE, TJ
    LANK, BA
    KORNACHUK, E
    GURWITH, MJ
    HARDING, GKM
    RONALD, AR
    CANCER, 1983, 51 (09) : 1587 - 1592
12345